Please provide your email address to receive an email when new articles are posted on . MicroOptx has completed enrollment in the initial phase of its FDA investigational device exemption clinical ...
MINNEAPOLIS, July 30, 2020 /PRNewswire/ -- MicroOptx Inc., a medical device innovator with a platform technology to change the way the world treats glaucoma, today announced the completion of ...
Please provide your email address to receive an email when new articles are posted on . “It is the first and only device shunting the aqueous to a location that is not the subconjunctival space, nor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results